Search results
Results from the WOW.Com Content Network
Paliperidone, sold under the brand name Invega among others, is an atypical antipsychotic. [14] It is indicated in the treatment of schizophrenia and schizoaffective disorder . [ 14 ] It is marketed by J&J Innovative Medicine
Radiation therapy at doses around "23.4 Gy" was found to cause cognitive decline that was especially apparent in young children who underwent the treatment for cranial tumors, between the ages of 5 and 11. Studies found, for example, that the IQ of 5-year-old children declined each year after treatment by additional several IQ points, thereby ...
Occasional memory loss can happen to anyone, no matter how old you are. Sometimes there is an external cause, related to how you are living your life — and making changes to your life can help ...
His teachers reported continued deficits in memory function, new learning efficiency, verbal reasoning skills, organizational skills, attention, and concentration, deficits which were confirmed by neuropsychological testing; as such, stopping the treatment with steroids brought on a substantial but incomplete relief, the damage being possibly ...
The evaluation of TGA focuses on ruling out other conditions that can cause memory loss: An imaging study (CT or MRI) may be done since (rarely) a bleed into the brain or even a brain tumor can ...
Both substance use and alcohol can cause both long-term and short-term memory loss, resulting in blackouts. The most commonly used group of prescription drugs which can produce amnesia are benzodiazepines, especially if combined with alcohol, however, in limited quantities, triazolam (Halcion) is not associated with amnesia or memory impairment ...
Since it is difficult to measure extrapyramidal symptoms, rating scales are commonly used to assess the severity of movement disorders. The Simpson-Angus Scale (SAS), Barnes Akathisia Rating Scale (BARS), Abnormal Involuntary Movement Scale (AIMS), and Extrapyramidal Symptom Rating Scale (ESRS) are rating scales frequently used for such assessment and are not weighted for diagnostic purposes ...
U.S. District Judge Claire Cecchi determined in Teva's case in 2021 that it failed to prove that J&J's patent, covering a dosing regimen for Invega Sustenna, was invalid. Viatris agreed to be ...